Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency...

    2026-03-07

    Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency DNA Transfection for In Vitro Studies

    Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely used for DNA transfection in mammalian cell lines, achieving efficiencies of 60–80% in serum-containing media under optimal conditions (APExBIO product data; Li et al., 2025). PEI forms stable DNA complexes that promote endocytosis-mediated uptake. The reagent is applicable for both small-scale and bioreactor workflows and supports transient recombinant protein production. Protocol optimization is essential for cell-type specificity and reproducibility. PEI's mechanism and efficacy are underpinned by peer-reviewed and vendor data, offering a reliable tool for in vitro gene delivery.

    Biological Rationale

    Efficient DNA transfection is fundamental for studying gene function, producing recombinant proteins, and modeling disease in vitro. Mammalian cell membranes are negatively charged due to abundant sialic acid and proteoglycans, which impede passive entry of nucleic acids. Polyethylenimine Linear (PEI, MW 40,000)—a synthetic, linear polycation—addresses this barrier by condensing DNA and facilitating its delivery into the cytoplasm (APExBIO). The linear formulation is preferred over branched forms for higher transfection efficiency and lower cytotoxicity in many cell types (tdTomato mRNA article). PEI is compatible with serum, making it suitable for routine and advanced molecular biology workflows.

    Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

    PEI, a polycationic amine polymer, condenses negatively charged DNA into nano-sized complexes via electrostatic interactions. These PEI/DNA complexes possess a net positive charge, enabling strong adherence to the anionic cell surface. Following binding, the complexes are internalized predominantly via clathrin-mediated endocytosis (Li et al., 2025). Once inside endosomes, the high buffering capacity of PEI induces the 'proton sponge effect,' causing osmotic swelling and disruption of the endosomal membrane, which releases DNA into the cytoplasm. Linear PEI (MW 40,000) is engineered for optimal balance between transfection efficiency and cell viability, with studies confirming its role in transient gene expression and recombinant protein production (Transfection-Kit.com). This article extends previous mechanistic discussions by detailing the proton sponge effect and highlighting PEI’s compatibility with complex cell culture media.

    Evidence & Benchmarks

    • PEI (MW 40,000) facilitates DNA transfection efficiencies of 60–80% in HEK-293, HeLa, and CHO-K1 cells in serum-containing media (Li et al., 2025).
    • PEI-mediated transfection supports both small-scale (96-well plate) and large-scale (up to 100 L bioreactor) workflows (APExBIO).
    • Linear formulations (vs. branched) reduce cytotoxicity and improve reproducibility in transient gene expression (Cy7-5 NHS Ester article).
    • PEI-DNA complexes remain stable and functionally active in the presence of 10% fetal bovine serum (FBS), unlike many lipid-based reagents (Z-DQMD-FMK article).
    • Endocytosis is the primary uptake mechanism, as confirmed by pharmacological inhibition studies (Li et al., 2025).

    Applications, Limits & Misconceptions

    Polyethylenimine Linear (PEI, MW 40,000) is broadly applied in in vitro functional genomics, recombinant protein expression, and disease modeling. It is frequently used with HEK-293, CHO-K1, HepG2, and HeLa cells for transient transfection (product page). This reagent enables high-yield protein production and supports assays in neuroinflammation and immunometabolism (Li et al., 2025). Compared to mRNA nanoparticle approaches, PEI remains a preferred DNA transfection reagent due to its scalability and simplicity, as previously reviewed (Ampicillin.co article). Here, we clarify that PEI is not suitable for primary neuronal cultures or in vivo gene delivery, where toxicity and delivery barriers are pronounced.

    Common Pitfalls or Misconceptions

    • PEI is not recommended for in vivo gene delivery due to toxicity and poor biodistribution (Li et al., 2025).
    • Transfection efficiency varies dramatically between cell types and must be empirically optimized.
    • Repeated freeze-thaw cycles degrade PEI and reduce activity; aliquoting and proper storage at 4°C or -20°C are critical (APExBIO).
    • PEI is less effective for RNA transfection compared to specialized lipid-based or polymeric mRNA reagents.
    • Excessive PEI:DNA ratios can result in cytotoxicity without increasing transfection yield.

    Workflow Integration & Parameters

    PEI (MW 40,000) is supplied by APExBIO at a 2.5 mg/mL stock concentration in 4 mL and 8 mL vials. For routine use, storage at 4°C is recommended to avoid freeze-thaw cycles; for long-term storage, -20°C is preferred. A standard protocol involves mixing PEI and DNA at a 1:3 mass ratio (e.g., 1 μg DNA : 3 μg PEI), followed by a 10–20 minute incubation at room temperature in a neutral buffer (e.g., PBS, pH 7.4). Complexes are then added dropwise to cells in serum-containing media. Transfection is typically assessed 24–48 hours post-addition. For scaling up, the protocol is directly adaptable to bioreactor volumes. This workflow is compatible with high-throughput screening and transient protein production (see protocol optimization guide—this article extends their scenario-driven advice with quantitative stability data).

    Conclusion & Outlook

    Polyethylenimine Linear (PEI, MW 40,000) remains a gold standard transfection reagent for in vitro DNA delivery, balancing efficiency, reproducibility, and cost-effectiveness. It is especially suited for transient gene expression and high-yield recombinant protein production in cell lines such as HEK-293 and CHO-K1. Ongoing optimization of PEI protocols and emerging combinatorial approaches promise to further improve efficacy and reduce cytotoxicity. For deeper insights into polymer payload engineering and epigenetic workflow integration, see this article—the current synthesis clarifies molecular mechanisms and context-specific limitations compared to previous reviews.